ArticleBrain and behavior2022

Real-world evidence following a mandatory treatment break after a 1-year prophylactic treatment with calcitonin gene-related peptide (pathway) monoclonal antibodies.

Michael Nsaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.